Burkhard Weisser

Prof. Dr. Burkhard Weisser

Director Dep. of Sports Medicine, Institute of Sports Science, Christian-Albrechts-University of Kiel, 24118 Kiel, Germany

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 1993 in Journal Of Hypertension
Verified
Journal Article
Closed access
TMThomas Mengden
Thomas Mengden
BBBenedikt Binswanger
Benedikt Binswanger
TSThomas Spühler
Thomas Spühler
Burkhard WeisserBurkhard Weisser
Burkhard Weisser
WVWilhelm Vetter
Wilhelm Vetter
To test whether the time of administration influences the therapeutic response to a calcium antagonist taken once a day. Also, the dynamics of drug compliance and its impact on blood pressure control were investigated. Twenty outpatients with mild-to-moderate hypertension were included in a randomized, placebo-controlled open study. In a crossover design, all of the patients received 5 mg amlodipine, either in the morning or in the evening, during two consecutive 4-week treatment periods. Blood pressure was taken by casual measurement, ambulatory 24-h monitoring (SpaceLabs 90202) and self-measurement at home, performed with a semi-automatic oscillometric device during the whole study period. Compliance was assessed using the Medication-Event-Monitoring System (MEMS). Neither casual nor ambulatory day- or night-time readings detected a significant difference between morning and evening administration. However, self-measurement documented significantly greater blood pressure reductions for morning than for evening administration. The MEMS showed different compliance on the days of ambulatory monitoring (100% with both drug regimens) compared with the whole treatment period. The number of days with missed medication was thus significantly higher for the evening dosing regimen. The difference in self-measured blood pressure between the two regimens was lost if the days with missed medication were removed from the statistical analysis. Time of once-a-day amlodipine administration does not influence its efficacy for 24-h blood pressure control. Furthermore, the use of self-measurement and the MEMS may provide useful additional information on the pharmacodynamic impact of different dosing patterns in hypertensive patients.

26 March 2020 in High Blood Pressure & Cardiovascular Prevention
Verified
Journal Article
Open access
PDF file
Burkhard WeisserBurkhard Weisser
Burkhard Weisser
HPHans-Georg Predel
Hans-Georg Predel
AGAnton Gillessen
Anton Gillessen
CHClaudia Hacke
Claudia Hacke
JEJohannes Vor Dem Esche
Johannes Vor Dem Esche
OROlaf Randerath
Olaf Randerath
Introduction Cardiovascular diseases (CVD) represent the first cause of mortality in western countries. Hypertension and dyslipidemia are strong risk factors for CVD, and are prevalent either alone or in combination. Although effective substances for the treatment of both factors are available, there is space for optimization of treatment regimens due to poor patient’s adherence to medication, which is usually a combination of several substances. Adherence decreases with the number of pills a patient needs to take. A combination of substances in one single-pill (single pill combination, SPC), might increase adherence, and lead to a better clinical outcome. Aim We conducted a meta-analysis to compare the effect of SPC with that of free-combination treatment (FCT) in patients with either hypertension, dyslipidemia or the combination of both diseases under conditions of daily practice. Methods Studies were identified by searching in PubMed from November 2014 until February 2015. Search criteria focused on trials in identical hypertension and/or dyslipidemia treatment as FCT therapy or as SPC. Adherence and persistence outcome included proportion-of-days-covered (PDC), medication possession ratio (MPR), time-to treatment gap of 30 and 60 days and no treatment gap of 30 days (y/n). Clinical outcomes were all cause hospitalisation, hypertension-related hospitalisation, all cause emergency room visits, hypertension-related emergency room visits, outpatient visits, hypertension-related outpatient visits, and number of patients reaching blood pressure goal. Randomized clinical studies were excluded because they usually do not reflect daily practice. Results 11 out of 1.465 studies met the predefined inclusion criteria. PDC ≥ 80% showed an odds ratio (OR) of 1.78 (95% CI: 1.30–2.45; p = 0.004) after 6 months and an OR of 1.85 (95% CI: 1.71; 2.37; p < 0.001) after ≥ 12 months in favour to the SPC. MPR ≥ 80% after 12 months also was in favour to SPC (OR 2.13; 95% CI: 1.30; 3.47; p = 0.003). Persistence was positively affected by SPC after 6, 12, and 18 months. Time to treatment gap of 60 days resulted in a hazard ratio (HR) of 2.03 (95% CI: 1.77; 2.33, p < 0.001). The use of SPC was associated with a significant improvement in systolic blood pressure reduction, leading to a higher number of patients reaching individual blood pressure goals (FCT vs SPC results in OR = 0.77; 95% CI: 0.69; 0.85, p < 0.001). Outpatient visits, emergency room visits and hospitalisations, both overall and hypertension-related were reduced by SPC: all-cause hospitalisation (SPC vs FCT: 15.0% vs 18.2%, OR 0.79, 95% CI 0.67; 0.94, p = 0.009), all-cause emergency room visits (SPC vs FCT: 25.7% vs 31.4%, OR 0.75, 95% CI 0.65; 0.87, p = 0.001) and hypertension related emergency room visits (SPC vs FCT: 9.7% vs 14.1%, OR 0.65, 95% CI 0.54; 0.80, p < 0.001). Conclusions SPC improved medication adherence and clinical outcome parameter in patients suffering from hypertension and/or dyslipidemia and led to a better clinical outcome compared to FCT under conditions of daily practice.

14 February 2014 in The Journal of Headache and Pain
Verified
Journal Article
Open access
PDF file
COClaudia H Overath
Claudia H Overath
SDStephanie Darabaneanu
Stephanie Darabaneanu
MEMarie C Evers
Marie C Evers
WGWolf-Dieter Gerber
Wolf-Dieter Gerber
MGMelanie Graf
Melanie Graf
Burkhard WeisserBurkhard Weisser
Burkhard Weisser
Migraine is a disorder of central information processing which is characterized by a reduced habituation of event-related potentials. There might be positive effects of aerobic exercise on brain function and pain. The aim of this study was to investigate the influence of exercise on information processing and clinical course of migraine.

1 July 2002 in Kidney and Blood Pressure Research
Verified
Journal Article
Closed access
PDF file
ARAnnette Reissinger
Annette Reissinger
MLMichael Ludwig
Michael Ludwig
BUBoris Utsch
Boris Utsch
APAstrid Prömse
Astrid Prömse
JBJohannes Baulmann
Johannes Baulmann
DBDirk Bokemeyer
Dirk Bokemeyer
Background: Gitelman’s syndrome (GS) is characterized by hypokalemic metabolic alkalosis, hypomagnesemia and hypocalciuria and these phenotypic features have been shown to be attributable to mutations in the gene encoding the thiazide-sensitive Na/Cl cotransporter (NCCT). Until now, 55 different mutations have been reported and most of the families affected with GS exhibit autosomal recessive inheritance. Methods: All 26 exons of the human NCCT  gene were investigated in 2 German NCCT-deficient patients and their families. Mutation detection was performed by either direct automated sequencing of polymerase chain reaction (PCR)-amplified DNA products or by sequence analysis of cloned PCR products. Results: In a 47-year-old German GS female a novel non-conservative missense mutation (S314F) and a complex deletion/insertion in the NCCT gene were found to be associated with the disorder. A further novel non-conservative substitution (S402F) together with a frequently observed R209W exchange were found in a 19-year-old German GS female. Conclusions: The observation of a compound heterozygote state in both females affected and the absence of a GS phenotype in their relatives carrying a single mutant allele is consistent with an autosomal recessive pattern of inheritance.

1 March 2019 in Gait & Posture
Verified
Journal Article
Closed access
JSJana Seuthe
Jana Seuthe
NDNicholas D'Cruz
Nicholas D'Cruz
Pieter GinisPieter Ginis
Pieter Ginis
Burkhard WeisserBurkhard Weisser
Burkhard Weisser
DBDaniela Berg
Daniela Berg
CSChristian Schlenstedt
Christian Schlenstedt

1 January 1991 in Drug Safety
Verified
Journal Article
Closed access
PDF file
ASAlbert Steiner
Albert Steiner
Burkhard WeisserBurkhard Weisser
Burkhard Weisser
WVWilhelm Vetter
Wilhelm Vetter